0001447362-20-000101.txt : 20200604 0001447362-20-000101.hdr.sgml : 20200604 20200604160726 ACCESSION NUMBER: 0001447362-20-000101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200602 FILED AS OF DATE: 20200604 DATE AS OF CHANGE: 20200604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Spiess Bernhard E. CENTRAL INDEX KEY: 0001782994 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38984 FILM NUMBER: 20943005 MAIL ADDRESS: STREET 1: C/O CASTLE BIOSCIENCES, INC. STREET 2: 820 S. FRIENDSWOOD DRIVE, SUITE 201 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC CENTRAL INDEX KEY: 0001447362 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770701744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 820 S FRIENDSWOOD DRIVE STREET 2: SUITE 201 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 BUSINESS PHONE: 866-788-9007 MAIL ADDRESS: STREET 1: 820 S FRIENDSWOOD DRIVE STREET 2: SUITE 201 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 4 1 wf-form4_159130122788334.xml FORM 4 X0306 4 2020-06-02 0 0001447362 CASTLE BIOSCIENCES INC CSTL 0001782994 Spiess Bernhard E. C/O CASTLE BIOSCIENCES, INC. 820 S. FRIENDSWOOD DRIVE, STE. 201 FRIENDSWOOD TX 77546 0 1 0 0 Chief Business Officer Common Stock 2020-06-02 4 S 0 31833 38.18 D 126026 D Common Stock 2020-06-02 4 S 0 400 38.94 D 125626 D This transaction was executed in multiple trades at prices ranging from $37.93 to $38.92, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $38.93 to $38.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Greg Acosta, Attorney-in-fact 2020-06-04